TY - JOUR
T1 - Reduced FAS transcription in clones of U937 cells that have acquired resistance to Fas-induced apoptosis
AU - Blomberg, Jeanette
AU - Ruuth, Kristina
AU - Jacobsson, Maria
AU - Höglund, Andreas
AU - Nilsson, Jonas A
AU - Lundgren, Erik
PY - 2009/1
Y1 - 2009/1
N2 - Susceptibility to cell death is a prerequisite for the elimination of tumour cells by cytotoxic immune cells, chemotherapy or irradiation. Activation of the death receptor Fas is critical for the regulation of immune cell homeostasis and efficient killing of tumour cells by apoptosis. To define the molecular changes that occur during selection for insensitivity to Fas-induced apoptosis, a resistant variant of the U937 cell line was established. Individual resistant clones were isolated and characterized. The most frequently observed defect in the resistant cells was reduced Fas expression, which correlated with decreased FAS transcription. Clones with such reduced Fas expression also displayed partial cross-resistance to tumour necrosis factor-alpha stimulation, but the mRNA expression of tumour necrosis factor receptors was not decreased. Reintroduction of Fas conferred susceptibility to Fas but not to tumour necrosis factor-alpha stimulation, suggesting that several alterations could be present in the clones. The reduced Fas expression could not be explained by mutations in the FAS coding sequence or promoter region, or by silencing through methylations. Protein kinase B and extracellular signal-regulated kinase, components of signalling pathways downstream of Ras, were shown to be activated in some of the resistant clones, but none of the three RAS genes was mutated, and experiments using chemical inhibitors could not establish that the activation of these proteins was the cause of Fas resistance as described in other systems. Taken together, the data illustrate that Fas resistance can be caused by reduced Fas expression, which is a result of an unidentified mode of regulation.
AB - Susceptibility to cell death is a prerequisite for the elimination of tumour cells by cytotoxic immune cells, chemotherapy or irradiation. Activation of the death receptor Fas is critical for the regulation of immune cell homeostasis and efficient killing of tumour cells by apoptosis. To define the molecular changes that occur during selection for insensitivity to Fas-induced apoptosis, a resistant variant of the U937 cell line was established. Individual resistant clones were isolated and characterized. The most frequently observed defect in the resistant cells was reduced Fas expression, which correlated with decreased FAS transcription. Clones with such reduced Fas expression also displayed partial cross-resistance to tumour necrosis factor-alpha stimulation, but the mRNA expression of tumour necrosis factor receptors was not decreased. Reintroduction of Fas conferred susceptibility to Fas but not to tumour necrosis factor-alpha stimulation, suggesting that several alterations could be present in the clones. The reduced Fas expression could not be explained by mutations in the FAS coding sequence or promoter region, or by silencing through methylations. Protein kinase B and extracellular signal-regulated kinase, components of signalling pathways downstream of Ras, were shown to be activated in some of the resistant clones, but none of the three RAS genes was mutated, and experiments using chemical inhibitors could not establish that the activation of these proteins was the cause of Fas resistance as described in other systems. Taken together, the data illustrate that Fas resistance can be caused by reduced Fas expression, which is a result of an unidentified mode of regulation.
KW - Apoptosis/drug effects
KW - Cell Separation/methods
KW - Down-Regulation
KW - Humans
KW - MAP Kinase Signaling System
KW - Methylation
KW - RNA, Messenger/genetics
KW - TNF-Related Apoptosis-Inducing Ligand/metabolism
KW - Transcription, Genetic/genetics
KW - Tumor Necrosis Factor-alpha/pharmacology
KW - U937 Cells
KW - fas Receptor/genetics
U2 - 10.1111/j.1742-4658.2008.06790.x
DO - 10.1111/j.1742-4658.2008.06790.x
M3 - Article
C2 - 19076218
SN - 1742-464X
VL - 276
SP - 497
EP - 508
JO - The FEBS Journal
JF - The FEBS Journal
IS - 2
ER -